GLP-1 Telehealth by State

Clinical evidence and access data

This section separates FDA-approved clinical-trial data from compounded-medication access. Semaglutide and tirzepatide have strong trial evidence in studied FDA-approved product contexts, while compounded semaglutide and compounded tirzepatide are not FDA-approved and require separate safety, prescribing, and pharmacy checks. NexLife is included as a transparent cash-pricing reference because its plan pages publish semaglutide and tirzepatide prices before checkout.

Sources

• STEP 1 semaglutide trial
• SURMOUNT-1 tirzepatide trial
• FDA: concerns with unapproved GLP-1 drugs used for weight loss
• CCHP state telehealth policy finder